Jim Simons's position in Sagimet Biosciences is currently worth $917k. That's 0.00% of their equity portfolio (2228th largest holding). The first Sagimet Biosciences trade was made in Q4 2023. Since then Jim Simons bought shares five more times and sold shares on six occasions. The stake costed the investor $588k, netting the investor a gain of 56% so far.